Amandine Le Bourgeois

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Élie Azoulay, Pedro Castro, Adel Maamar et al. · The Lancet Haematology · 2021 · 99 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

Amandine Le Bourgeois, Marianne Coste‐Burel, Thierry Guillaume et al. · JAMA Network Open · 2021 · 65 citations · Full text

Veterinary Medicine, Hematology, Immunology +14

Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life

Clara Sortais, Anne Lok, Benoît Tessoulin et al. · Annals of Hematology · 2020 · 48 citations

Medicine, Hematology, Oncology +8

Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide

Catherine Willem, Dhon Roméo Makanga, Thierry Guillaume et al. · The Journal of Immunology · 2019 · 44 citations

Medicine, Hematology, Immunology +17

Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Thierry Guillaume, Sylvain Thépot, Pierre Péterlin et al. · Transplantation and Cellular Therapy · 2021 · 44 citations · Full text

Medicine, Hematology, Pharmacotherapy +17